Financial_NNP Statements_NNP 107_NNP 23_CD POST-RETIREMENT_NNP BENEFITS_NNP Pensions_NNP Background_NNP The_NNP Company_NNP and_CC most_JJS of_IN its_PRP$ subsidiaries_NNS offer_VBP retirement_NN plans_NNS which_WDT cover_VBP the_DT majority_NN of_IN employees_NNS in_IN the_DT Group_NNP ._.
Many_JJ of_IN these_DT plans_NNS are_VBP defined_VBN contribution_NN ,_, where_WRB the_DT company_NN contribution_NN and_CC resulting_VBG income_NN statement_NN charge_NN is_VBZ fixed_VBN at_IN a_DT set_VBN level_NN or_CC is_VBZ a_DT set_NN percentage_NN of_IN employees_NNS pay_VBP ._.
However_RB ,_, several_JJ plans_NNS ,_, mainly_RB in_IN the_DT UK_NNP ,_, the_DT US_NNP and_CC Sweden_NNP ,_, are_VBP defined_VBN benefit_NN ,_, where_WRB benefits_NNS are_VBP based_VBN on_IN employees_NNS length_NN of_IN service_NN and_CC average_JJ final_JJ salary_NN typically_RB averaged_VBD over_IN 1_CD ,_, 3_CD or_CC 5_CD years_NNS ._.
The_DT major_JJ plans_NNS are_VBP funded_VBN through_IN legally_RB separate_JJ trusteeadministered_VBN funds_NNS ._.
The_DT major_JJ defined_VBN benefit_NN plans_NNS ,_, apart_RB from_IN the_DT collectively_RB bargained_VBN Swedish_JJ plan_NN ,_, have_VBP been_VBN closed_VBN to_TO new_JJ entrants_NNS since_IN 2000_CD ._.
The_DT cash_NN funding_NN of_IN the_DT plans_NNS ,_, which_WDT may_MD from_IN time_NN to_TO time_NN involve_VB special_JJ payments_NNS ,_, is_VBZ designed_VBN ,_, in_IN consultation_NN with_IN independent_JJ qualified_JJ actuaries_NNS ,_, to_TO ensure_VB that_IN the_DT assets_NNS together_RB with_IN future_JJ contributions_NNS should_MD be_VB sufficient_JJ to_TO meet_VB future_JJ obligations_NNS ._.
The_DT funding_NN is_VBZ monitored_JJ rigorously_RB by_IN the_DT Company_NN and_CC appropriate_JJ fiduciaries_NNS specifically_RB with_IN reference_NN to_TO the_DT Companys_NNPS credit_NN rating_NN ,_, market_NN capitalization_NN and_CC cash_NN flows_NNS ._.
Post-retirement_NN scheme_NN deficit_NN The_DT assets_NNS and_CC obligations_NNS of_IN the_DT major_JJ defined_VBN benefit_NN schemes_NNS operated_VBN by_IN the_DT Group_NNP at_IN 31_CD December_NNP 2005_CD as_IN calculated_VBN in_IN accordance_NN with_IN IAS_NNP 19_CD are_VBP shown_VBN below_IN ._.
The_DT fair_JJ values_NNS of_IN the_DT schemes_NNS assets_NNS are_VBP not_RB intended_VBN to_TO be_VB realized_VBN in_IN the_DT short_JJ term_NN and_CC may_MD be_VB subject_JJ to_TO significant_JJ change_NN before_IN they_PRP are_VBP realized_VBN ._.
The_DT present_JJ value_NN of_IN the_DT schemes_NNS obligations_NNS is_VBZ derived_VBN from_IN cash_NN flow_NN projections_NNS over_IN long_JJ periods_NNS and_CC is_VBZ thus_RB inherently_RB uncertain_JJ ._.
UK_NNP With_IN regard_NN to_TO the_DT Groups_NNS main_JJ UK_NNP defined_VBD benefit_NN fund_NN ,_, the_DT most_RBS recent_JJ full_JJ actuarial_JJ valuation_NN was_VBD carried_VBN out_RP at_IN 31_CD March_NNP 2003_CD and_CC the_DT pension_NN cost_NN assessed_VBN using_VBG the_DT projected_VBN unit_NN credit_NN method_NN ._.
Since_IN then_RB the_DT Company_NN has_VBZ paid_VBN both_DT single_JJ and_CC regular_JJ contributions_NNS to_TO fund_VB the_DT deficit_NN ,_, and_CC the_DT impact_NN of_IN these_DT has_VBZ been_VBN monitored_VBN through_IN interim_JJ valuations_NNS in_IN 2004_CD and_CC 2005_CD ._.
In_IN the_DT interim_JJ valuation_NN performed_VBN by_IN the_DT funds_NNS actuaries_NNS ,_, at_IN 31_CD March_NNP 2005_CD ,_, the_DT key_JJ assumptions_NNS ,_, set_VBN out_RP in_IN a_DT manner_NN consistent_JJ with_IN the_DT 2003_CD valuation_NN ,_, were_VBD revised_VBN having_VBG regard_NN to_TO the_DT investment_NN conditions_NNS at_IN 31_CD March_NNP 2005_CD ._.
The_DT long_JJ term_NN UK_NNP price_NN inflation_NN was_VBD set_VBN at_IN 2.75_CD %_NN pa_NN ,_, salary_NN increases_NNS at_IN 4.03_CD %_NN pa_NN ,_, pension_NN increases_NNS at_IN 2.75_CD %_NN pa_NN and_CC investment_NN returns_NNS at_IN 6.2_CD %_NN pa._NN ._.
The_DT market_NN value_NN of_IN the_DT funds_NNS assets_NNS at_IN the_DT valuation_NN date_NN was_VBD 2,625_CD m_NN $_$ 4,933_CD m_NN equivalent_NN ,_, representing_VBG 92.3_CD %_NN of_IN the_DT funds_NNS actuarially_RB assessed_VBN obligations_NNS ._.
Rest_VB of_IN Group_NNP The_DT US_NNP defined_VBD benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2005_CD when_WRB plan_NN obligations_NNS were_VBD $_$ 1,512_CD m_NN and_CC plan_NN assets_NNS were_VBD $_$ 1,329_CD m._FW The_DT US_NNP makes_VBZ contributions_NNS to_TO mitigate_VB for_IN plan_NN benefit_VBP deficits_NNS on_IN a_DT regular_JJ basis_NN ._.
The_DT Swedish_JJ defined_VBN benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2005_CD ,_, when_WRB plan_NN obligations_NNS were_VBD estimated_VBN to_TO amount_VB to_TO $_$ 713m_CD and_CC plan_NN assets_NNS were_VBD $_$ 545m_CD ._.
The_DT German_JJ defined_VBN benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2005_CD ,_, when_WRB plan_NN obligations_NNS amounted_VBD to_TO $_$ 209m_CD and_CC plan_NN assets_NNS were_VBD $_$ 27m_CD ._.
The_DT Japanese_JJ defined_VBN benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2005_CD ,_, when_WRB plan_NN obligations_NNS amounted_VBD to_TO $_$ 285m_CD and_CC plan_NN assets_NNS were_VBD $_$ 186m_CD ._.
The_DT majority_NN of_IN the_DT Japanese_JJ plan_NN obligations_NNS will_MD be_VB converted_VBN to_TO defined_VBN contribution_NN assets_NNS during_IN 2006_CD following_VBG employee_NN agreement_NN to_TO revise_VB the_DT Japanese_JJ benefits_NNS programs_NNS ._.
Post-retirement_NN benefits_NNS other_JJ than_IN pensions_NNS In_IN the_DT US_NNP ,_, and_CC to_TO a_DT lesser_JJR extent_NN in_IN certain_JJ other_JJ countries_NNS ,_, AstraZenecas_NNP employment_NN practices_NNS include_VBP the_DT provision_NN of_IN healthcare_NN and_CC life_NN insurance_NN benefits_NNS for_IN retired_VBN employees_NNS ._.
As_IN at_IN 31_CD December_NNP 2005_CD ,_, some_DT 3,694_CD retired_VBN employees_NNS and_CC covered_VBD dependants_NNS currently_RB benefit_VBP from_IN these_DT provisions_NNS and_CC some_DT 14,183_CD current_JJ employees_NNS will_MD be_VB eligible_JJ on_IN their_PRP$ retirement_NN ._.
AstraZeneca_NNP accrues_VBZ for_IN the_DT present_JJ value_NN of_IN such_JJ retiree_NN obligations_NNS over_IN the_DT working_VBG life_NN of_IN the_DT employee_NN ._.
The_DT cost_NN of_IN post-retirement_JJ benefits_NNS other_JJ than_IN pensions_NNS for_IN the_DT Group_NNP in_IN 2005_CD was_VBD $_$ 12m_CD 2004_CD $_$ 11m_CD ,_, 2003_CD $_$ 9m_CD ._.
Plan_NNP assets_NNS were_VBD $_$ 230m_CD and_CC plan_NN obligations_NNS were_VBD $_$ 257m_CD at_IN 31_CD December_NNP 2005_CD ._.
These_DT benefit_NN plans_NNS have_VBP been_VBN included_VBN in_IN the_DT disclosure_NN of_IN post-retirement_JJ benefits_NNS under_IN IAS_NNP 19_CD ._.
AstraZeneca_NNP Annual_JJ Report_NNP and_CC 108_CD Form_NN 20-F_JJ Information_NN 2005_CD NOTES_NNS TO_TO THE_DT FINANCIAL_NNP STATEMENTS_NNS CONTINUED_VBD 23_CD POST-RETIREMENT_NNP BENEFITS_NNP CONTINUED_VBD Financial_NNP assumptions_NNS Qualified_VBN independent_JJ actuaries_NNS have_VBP updated_VBN the_DT actuarial_JJ valuations_NNS of_IN the_DT major_JJ defined_VBN benefit_NN schemes_NNS operated_VBN by_IN the_DT Group_NNP to_TO 31_CD December_NNP 2005_CD ._.
The_DT assumptions_NNS used_VBN by_IN the_DT actuaries_NNS are_VBP chosen_VBN from_IN a_DT range_NN of_IN possible_JJ actuarial_JJ assumptions_NNS which_WDT ,_, due_JJ to_TO the_DT long_JJ term_NN nature_NN of_IN the_DT scheme_NN ,_, may_MD not_RB necessarily_RB be_VB borne_VBN out_RP in_IN practice_NN ._.
These_DT assumptions_NNS were_VBD as_IN follows_VBZ :_: 2005_CD 2004_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP UK_NNP Group_NNP Inflation_NN assumption_NN 2.7_CD %_NN 2.1_CD %_NN 2.7_CD %_NN 2.4_CD %_NN Rate_NN of_IN increase_NN in_IN salaries_NNS 3.9_CD %_NN 3.5_CD %_NN 3.9_CD %_NN 3.9_CD %_NN Rate_NN of_IN increase_NN in_IN pensions_NNS in_IN payment_NN 2.7_CD %_NN 0.7_CD %_NN 2.7_CD %_NN 0.7_CD %_NN Discount_NNP rate_NN 4.9_CD %_NN 4.6_CD %_NN 5.3_CD %_NN 5.1_CD %_NN Long_JJ term_NN rate_NN of_IN return_NN expected_VBN at_IN 31_CD December_NNP Equities_NNPS 8.3_CD %_NN 7.9_CD %_NN 8.3_CD %_NN 8.6_CD %_NN Bonds_NNS 5.1_CD %_NN 5.6_CD %_NN 5.1_CD %_NN 5.3_CD %_NN Others_NNS 5.6_CD %_NN 4.4_CD %_NN 5.6_CD %_NN 4.7_CD %_NN Rate_NN of_IN increase_NN in_IN medical_JJ costs_NNS 9.0_CD %_NN 10.0_CD %_NN 8.0_CD %_NN 9.0_CD %_NN The_DT Group_NNP uses_VBZ certain_JJ mortality_NN rate_NN assumptions_NNS when_WRB calculating_VBG scheme_NN obligations_NNS ._.
The_DT current_JJ mortality_NN assumptions_NNS for_IN all_DT major_JJ schemes_NNS retain_VBP prudent_JJ allowance_NN for_IN future_JJ improvements_NNS in_IN longevity_NN and_CC take_VB account_NN of_IN experience_NN ._.
The_DT mortality_NN tables_NNS used_VBN for_IN the_DT major_JJ schemes_NNS are_VBP as_IN follows_VBZ :_: UK_NNP :_: PMA92_NN with_IN special_JJ AZ-specific_JJ adjustment_NN to_TO reflect_VB actual_JJ experience_NN as_IN investigated_VBN at_IN each_DT valuation_NN ,_, and_CC allowance_NN for_IN future_JJ improvement_NN US_NNP Qualified_NNP Plans_NNS :_: RP2000_CD Sweden_NNP :_: P94_NNP Japan_NNP :_: National_NNP Census_NNP No._NN ._.
18_CD Life_NNP Table_NNP Germany_NNP :_: Huebeck_NNP tables_NNS 2005G_NNP The_DT expected_VBN return_NN on_IN assets_NNS is_VBZ determined_VBN with_IN reference_NN to_TO the_DT expected_VBN long_JJ term_NN level_NN of_IN dividends_NNS ,_, interest_NN and_CC other_JJ returns_NNS derived_VBN from_IN the_DT plan_NN assets_NNS ,_, together_RB with_IN realized_VBN and_CC unrealised_JJ gains_NNS or_CC losses_NNS on_IN the_DT plan_NN assets_NNS ,_, less_JJR any_DT costs_NNS of_IN administering_VBG the_DT plan_NN ,_, less_JJR any_DT tax_NN payable_JJ by_IN the_DT plan_NN ._.
The_DT expected_JJ returns_NNS are_VBP based_VBN on_IN long_JJ term_NN market_NN expectations_NNS and_CC analyzed_VBD on_IN a_DT regular_JJ basis_NN to_TO ensure_VB any_DT sustained_VBN movements_NNS in_IN underlying_VBG markets_NNS are_VBP reflected_VBN ._.
Sensitivity_NN of_IN medical_JJ cost_NN assumption_NN Effect_NN of_IN change_NN in_IN medical_JJ cost_NN assumption_NN 2005_CD 2004_CD 1_CD %_NN 1_CD %_NN 1_CD %_NN 1_CD %_NN Current_JJ service_NN and_CC interest_NN cost_NN of_IN net_JJ periodic_JJ post-employment_NN medical_JJ costs_NNS 2_CD 1_CD 2_CD 2_CD Accumulated_VBN post-employment_NN benefit_NN obligation_NN for_IN medical_JJ costs_NNS 19_CD 15_CD 15_CD 13_CD Financial_NNP Statements_NNP 109_CD 23_CD POST-RETIREMENT_NNP BENEFITS_NNP CONTINUED_VBD 2005 2004 2003_CD UK_NNP Present_NNP value_NN of_IN defined_VBN benefit_NN obligations_NNS $_$ m_CD 6,309_CD 6,147_CD 5,252_CD Fair_NNP value_NN of_IN plan_NN assets_NNS $_$ m_CD 5,314_CD 5,007_CD 4,310_CD Deficit_NN in_IN the_DT scheme_NN $_$ m_CD 995_CD 1,140_CD 942_CD Experience_NN adjustments_NNS on_IN :_: Scheme_NN assets_NNS Amount_NNP $_$ m_CD 636 138 210_CD Percentage_NN of_IN scheme_NN assets_NNS 12.0_CD 2.8_CD 4.9_CD Scheme_NN obligations_NNS Amount_NNP $_$ m_CD 539 220 356_CD Percentage_NN of_IN scheme_NN obligations_NNS 8.5_CD 3.6_CD 6.8_CD Rest_VBP of_IN Group_NNP Present_NNP value_NN of_IN defined_VBN benefit_NN obligations_NNS $_$ m_CD 2,995_CD 2,811_CD 2,387_CD Fair_NNP value_NN of_IN plan_NN assets_NNS $_$ m_CD 2,284_CD 2,190_CD 1,801_CD Deficit_NN in_IN the_DT scheme_NN $_$ m_CD 711 621 586_CD Experience_NN adjustments_NNS on_IN :_: Scheme_NN assets_NNS Amount_NNP $_$ m_CD 63_CD 14_CD 75_CD Percentage_NN of_IN scheme_NN assets_NNS 2.8_CD 0.6_CD 4.2_CD Scheme_NN obligations_NNS Amount_NNP $_$ m_CD 195 111 169_CD Percentage_NN of_IN scheme_NN obligations_NNS 6.5_CD 4.0_CD 7.1_CD Total_JJ Present_JJ value_NN of_IN defined_VBN benefit_NN obligations_NNS $_$ m_CD 9,304_CD 8,958_CD 7,639_CD Fair_NNP value_NN of_IN plan_NN assets_NNS $_$ m_CD 7,598_CD 7,197_CD 6,111_CD Deficit_NN in_IN the_DT scheme_NN $_$ m_CD 1,706_CD 1,761_CD 1,528_CD Experience_NN adjustments_NNS on_IN :_: Scheme_NN assets_NNS Amount_NNP $_$ m_CD 699 152 285_CD Percentage_NN of_IN scheme_NN assets_NNS 9.2_CD 2.1_CD 4.7_CD Scheme_NN obligations_NNS Amount_NNP $_$ m_CD 734 331 525_CD Percentage_NN of_IN scheme_NN obligations_NNS 7.9_CD 3.7_CD 6.9_CD The_DT defined_VBN benefit_NN obligation_NN arises_VBZ from_IN the_DT following_VBG plans_NNS :_: 2005_CD 2004_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP UK_NNP Group_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Wholly_RB funded_VBN 6,282_CD 2,873_CD 6,114_CD 2,700_CD Unfunded_JJ 27_CD 122_CD 33_CD 111_CD Total_JJ 6,309_CD 2,995_CD 6,147_CD 2,811_CD AstraZeneca_NNP Annual_JJ Report_NNP and_CC 110_CD Form_NN 20-F_JJ Information_NN 2005_CD 23_CD POST-RETIREMENT_NNP BENEFITS_NNP CONTINUED_VBD Income_NNP statement_NN disclosures_NNS The_DT amounts_NNS that_WDT have_VBP been_VBN charged_VBN to_TO the_DT consolidated_JJ income_NN statement_NN and_CC consolidated_JJ statement_NN of_IN recognized_VBN income_NN and_CC expense_NN ,_, in_IN respect_NN of_IN defined_VBN benefit_NN schemes_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD are_VBP set_VBN out_RP below_IN :_: 2005_CD 2004_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Operating_NN profit_NN Current_JJ service_NN cost_NN 148 120 268 138_CD 116_CD 254_CD Finance_NNP expense_NN Expected_VBN return_NN on_IN post-retirement_JJ scheme_NN assets_NNS 296 152 448 278_CD 112_CD 390_CD Interest_NN on_IN post-retirement_JJ scheme_NN obligations_NNS 301 132 433 278_CD 120_CD 398_CD Net_JJ return_NN 5_CD 20_CD 15_CD 8_CD 8_CD Charge_NNP before_IN taxation_NN 153 100 253 138_CD 124_CD 262_CD Consolidated_NNP statement_NN of_IN recognized_VBN income_NN and_CC expense_NN Difference_NN between_IN the_DT actual_JJ return_NN and_CC the_DT expected_VBN return_NN on_IN the_DT post-retirement_JJ schemes_NNS assets_NNS 636 63 699 138_CD 14_CD 152_CD Experience_NN losses_NNS arising_VBG on_IN the_DT post-retirement_JJ schemes_NNS obligations_NNS 26_CD 47_CD 21_CD 57_CD 9_CD 66_CD Changes_NNS in_IN assumptions_NNS underlying_VBG the_DT present_JJ value_NN of_IN the_DT post-retirement_JJ schemes_NNS obligations_NNS 513 242 755 163_CD 102_CD 265_CD Actuarial_JJ gain_NN loss_NN recognized_VBN 97_CD 132_CD 35_CD 82_CD 97_CD 179_CD Movement_NNP in_IN post-retirement_JJ scheme_NN obligations_NNS 2005_CD 2004_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Present_JJ value_NN of_IN obligation_NN in_IN schemes_NNS at_IN beginning_NN of_IN year_NN 6,147_CD 2,811_CD 8,958_CD 5,252_CD 2,387_CD 7,639_CD Current_JJ service_NN cost_NN 148 120 268 138_CD 116_CD 254_CD Contributions_NNS 26_CD 6_CD 32_CD Benefits_NNS paid_VBN 228 92 320 213_CD 68_CD 281_CD Other_JJ finance_NN expense_NN 301 132 433 278_CD 120_CD 398_CD Actuarial_JJ loss_NN 539 195 734 220_CD 111_CD 331_CD Exchange_NNP 624 177 801 472_CD 145_CD 617_CD Present_JJ value_NN of_IN obligations_NNS in_IN schemes_NNS at_IN end_NN of_IN year_NN 6,309_CD 2,995_CD 9,304_CD 6,147_CD 2,811_CD 8,958_CD It_PRP is_VBZ expected_VBN that_IN the_DT contributions_NNS to_TO the_DT schemes_NNS during_IN the_DT year_NN ended_VBD 31_CD December_NNP 2006_CD will_MD be_VB $_$ 163m_CD ._.
Costs_NNS in_IN respect_NN of_IN defined_VBN contribution_NN schemes_NNS during_IN the_DT year_NN were_VBD $_$ 9m_CD ._.
